Biomarkers in Metabolic Syndrome
14 November 2017

This white paper highlights a potential application for LGCs Biomarker Testing Service. It discusses utilizing biomarkers in the study of metabolic syndrome, which leads to an increased risk of Cardiovascular Disease and Type 2 Diabetes.